Establishment and characterization of immortalized human cell lines from prostatic carcinoma and benign prostatic hyperplasia

International Journal of Oncology

Volumn 12, Issue 2, 1998, Pages 257-263

  Iype, P Thomas ^b   Iype, Lisa Elizabeth ^b   Verma, Mukesh ^a,b   Kaighn, M Edward ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Biol Res Fac and Facility Inc   (United States)

Author keywords

Benign prostatic hyperplasia; Immortalized cell lines; Prostate cancer; Prostate cell lines; Serum free medium

Indexed keywords

ANDROGEN RECEPTOR; CYTOKERATIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CELL IMMORTALIZATION; CELL STRUCTURE; CULTURE MEDIUM; EPITHELIUM CELL; HUMAN; HUMAN CELL; MALE; ONCOGENE H RAS; ONCOGENE K RAS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY;

EID: 0031933189     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.2.257     Document Type: Article

References (25)

1. Parker SL, Tong T, Bolden S and Wingo PA: Cancer statistics. CA - A Cancer J Clin 46: 5-27, 1996.
2. Stone KR, Mickey DD, Wunderli H, Mickey GH and Paulson DF: Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 21: 274-281, 1978.
3. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF and Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23, 1979.
4. Horoszewicz JS, Leong SS, Chu TM, et al: The LNCaP cell line - a new model for studies on human prostatic carcinoma. In: Models for Prostate Cancer. Murphy GP (ed). Alan R. Liss, Inc, NY, pp115-132, 1980.
5. Brothman AR, Wilkins PC, Sales EW and Somers KD: Metastatic properties of the human prostatic cell line, PPC-1, in athymic nude mice. J Urol 145: 1088-1091, 1991.
6. Gingrich JR, Tucker JA, Walther PJ, Day JW, Poulton SHM and Webb KS: Establishment and characterization of a new human prostatic carcinoma cell line (DuPro-1). J Urol 146: 915-919, 1991.
7. Narayan P and Dahiya R: Establishment and characterization of a human primary prostatic adenocarcinoma cell line (ND-1). J Urol 148: 1600-1604, 1992.
8. Kaighn ME, Reddel RR, Lechner JF, Peehl DM, Camalier RF, Brash DE, Saffiotti U and Harris CC: Transformation of human neonatal prostate epithelial cells by strontium phosphate transfection with a plasmid containing SV40 early region genes. Cancer Res 49: 3050-3056, 1989.
9. Cussenot O, Berthon P, Berger R, Mowszowicz I, Faille A, Hojman F, Teillac P, Le Duc A and Calvo F: Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. J Urol 146 :881-886, 1991.
10. Webber MM, Bello D, Kleinman HK, Wartinger DD, Williams DE and Rhim JS: Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line. Carcinogenesis 17: 1641-1646, 1996.
11. Hayward SW, Dahiya R, Cunha GR, Bartek J, Deshpande N and Narayan P: Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH- 1. In vitro Cell Dev Biol - Animal 31: 14-24, 1995.
12. Bright RK, Vocke CD, Emmert-Buck MR, Duray PH, Solomon D, Fetsch P, Rhim JS, Linchan WM and Topalian SL: Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res 57: 995-1002, 1997.
13. Stoner GD, Kaighn ME, Reddel RR, Resau JH, Bowman D, Naito Z, Matsukura N, You M, Galati AJ and Harris CC: Establishment and characterization of SV40 t-antigen immortalized human esophageal epithelial cells. Cancer Res 51: 365-371, 1991.
14. Lechner JF and LaVeck MA: A serum-free method for culturing normal human bronchial epithelial cells at clonal density. J Tissue Culture Methods 9: 43-48, 1985.
15. Iype PT, Kumari LH, Kaighn ME and Hukku B: On the use of Syrian hamster cell cultures as targets for carcinogen-screening. Int J Oncol 7: 603-609, 1995.
16. Reddel RR, Ke Y, Gerwin BI, et al: Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 48: 1904-1909, 1988.
17. Driscoll KE, Carter JM, Iype PT, Kumari HL, Crosby LL, Aardema MJ, Isfort RJ, Cody D, Chestnut MH, Burns JL and LeBoeuf RA: Establishment of immortalized alveolar type II epithelial cell lines from adult rats. In vitro Cell Dev Biol - Animal 31: 516-527, 1995.
18. Kaighn ME, Lechner JF, Narayan KS and Jones LW: Prostate carcinoma: tissue culture cell lines. Natl Cancer Inst Monogr 49: 17-21, 1978.
19. Verhagen APM, Ramaekers FCS, Aalders TW, Schaafsma HE, Debruyne FMJ and Schalken JA: Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res 52: 6182-6187, 1992.
20. Yan R, Ottenbreit M, Hukku B, Mally M, Chou S and Kaplan J: DNA fingerprinting of human cell lines using PCR amplification of fragment length polymorphisms. In vitro Cell Dev Biol - Animal 32: 656-662, 1996.
21. Traweek ST, Liu J and Battifora H: Keratin gene expression in non-epithelial tissues. Am J Pathol 142: 1111-1118, 1993.
22. Berthois Y, Katzenellenbogen JA and Katzenellenbogen BS: Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83: 2496-2500, 1986.
23. Leube RE, Bosch FX, Romano V, Zimbelmann R, Hofler H and Franke WW: Cytokeratin expression in simple epithelia. Differentiation 33: 69-85, 1986.
24. Peehl DM, Wehner N and Stamey TA: Activated Ki-ras oncogene in human prostatic adenocarcinoma. Prostate 10: 281-289, 1987.
25. Voeller HJ, Sugars LY, Pretlow T and Gelmann EP: p53 oncogene mutations in human prostate cancer specimens. J Urol 151: 492-495, 1994.